Condensed Consolidated Balance Sheets (unaudited) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets
Cash	$ 27,810,526	$ 51,100,915
Accounts receivable, net	10,313,916	5,285,321
Related party receivables	32,685	366,590
Inventories, net	60,471,468	41,012,124
Prepaid expenses and other current assets	1,951,700	3,494,473
Total current assets	100,580,295	101,259,423
Restricted Cash	4,900,000	4,900,000
Property and equipment, net	30,764,406	27,030,400
Operating lease right-of-use assets, net	16,203,487	17,836,756
Finance right-of-use asset	716,402	883,076
Intangible assets, net	16,089,408	6,592,316
Goodwill	16,541,041	14,440,683
Investments	1,400,000	400,000
Equity-method investments	994,534	963,685
Other related party receivables	151,300	0
Other assets	1,045,460	993,538
Total assets	189,386,333	175,299,877
Current Liabilities
Accounts payable	25,693,495	16,889,756
Accrued payroll	2,927,550	2,526,917
Other accrued expenses	2,573,760	1,144,573
Related party payable	874,870	1,634,775
Current portion of operating lease liabilities	1,599,190	2,633,236
Current portion of finance lease liabilities	391,003	413,487
Current portion of long-term debt	508,844	494,173
Total current liabilities	34,568,712	25,736,917
Long-term Liabilities
Operating lease liabilities, net of current portion	27,026,923	27,605,739
Finance lease liabilities, net of current portion	348,352	482,544
Long-term debt, net of current portion	825,488	1,083,634
Warrant liability	1,529,586	2,058,566
Total liabilities	64,299,061	56,967,400
Commitments and Contingencies (Notes 11 and 16)
Stockholders' Deficit
Additional paid-in capital	255,557,384	250,163,984
Accumulated deficit	(132,769,662)	(132,158,016)
Accumulated other comprehensive loss	(186,200)	0
Total stockholders' equity (deficit)—Thorne HealthTech, Inc.	123,128,855	118,531,510
Non-controlling interest	1,958,417	(199,033)
Total stockholders' equity	125,087,272	118,332,477
Total liabilities, convertible preferred stock and stockholders' equity	189,386,333	175,299,877
Series E Preferred Stock [Member]
Long-term Liabilities
Series E convertible preferred stock; par value $0.01, 0 shares authorized as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021	0	0
Common Class B [Member]
Stockholders' Deficit
Common Stock, Value, Issued	0	0
Common Class Undefined [Member]
Stockholders' Deficit
Common Stock, Value, Issued	$ 527,333	$ 525,542